The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.
第一作者:
Rob,Lambkin-Williams
第一单位:
hVIVO Services Limited, Queen Mary BioEnterprises Innovation Centre, 42 New Road, London, England, E1 2AX, UK. rlw@hvivo.com.
作者:
关键词
Acute respiratory infections; Respiratory medicine; Controlled clinical trialDiagnosticFluGene switchingHuman boca virus (HBoV). TherapeuticsHuman rhinovirus (HRV)Immune responsePathogenicityPragmatic clinical trialsResearch and developmentRespiratory syncytial virus (RSV)Virus-host interactionsinfluenza
主题词
抗病毒药(Antiviral Agents);临床试验(主题)(Clinical Trials as Topic);药物评价, 临床前(Drug Evaluation, Preclinical);人类(Humans);流感, 人(Influenza, Human);呼吸道合胞体病毒感染(Respiratory Syncytial Virus Infections);呼吸道合胞体病毒, 人(Respiratory Syncytial Virus, Human);呼吸道感染(Respiratory Tract Infections);鼻病毒属(Rhinovirus);病毒载量(Viral Load);病毒疫苗(Viral Vaccines)
DOI
10.1186/s12931-018-0784-1
PMID
29929556
发布时间
2024-03-27
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



